Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Radiation beads show promise for liver tumors in small trial
Disease control CompletedThis study tested a treatment called TheraSphere for people with neuroendocrine tumors that have spread to the liver and cannot be removed by surgery. TheraSphere uses tiny radioactive beads delivered directly to the liver to kill cancer cells. The trial included 24 adults who ha…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 29, 2026 06:59 UTC
-
Can these drugs stop COVID-19 pneumonia from turning severe?
Disease control CompletedThis study tested two drugs, ruxolitinib and fostamatinib, in hospitalized adults with mild to moderate COVID-19 pneumonia. The goal was to see if either drug could prevent the disease from becoming severe, such as needing a breathing machine. Participants received the drug for 1…
Phase: PHASE1, PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Apr 29, 2026 06:59 UTC
-
Cancer Patients' COVID-19 journey revealed in massive study
Knowledge-focused CompletedThis study looked at 3820 adults with cancer who also had COVID-19. Researchers collected routine medical data to describe symptoms and identify factors that affect survival. The goal was to better understand how the virus impacts cancer patients, without testing any new treatmen…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Apr 29, 2026 06:58 UTC
-
RSV study aims to unlock immune secrets in older adults
Knowledge-focused CompletedThis study looked at how the immune system of older adults (ages 60-75) responds to the respiratory syncytial virus (RSV). Researchers exposed 28 healthy volunteers to a controlled dose of RSV to measure their immune reactions and track any side effects. The goal is to find bette…
Phase: NA • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC